Healthy high growth potential

Results

1532

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1532 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AAZ
UK£4.08-3.4%139.7%UK£465.9mUK£5.6835.725.9%0.7%Materials
MDGL
US$507.56-0.5%37.2%US$11.7bUS$678.069.163.7%n/aPharmaceuticals & Biotech
AGP
€7.262.8%-6.7%€132.4m€8.5726.639.1%n/aCapital Goods
LPK
€15.05-1.6%83.8%€368.0m€22.753.7116.6%0%Tech
KEBNI B
SEK 1.064.1%-51.1%SEK 291.0mSEK 1.252.690.9%n/aTech
FWRY
ج.م19.01-1.2%44.0%ج.م64.8bج.م22.4524.327.3%n/aDiversified Financials
CDR
zł263.102.7%6.7%zł26.3bzł234.5150.939.0%0.4%Media
RHM
€1,202.004.9%-25.8%€56.1b€1,677.0046.430.5%1.0%Capital Goods
NVDA
US$225.160.5%24.8%US$5.5tUS$302.8334.222.9%0.4%Semiconductors
AXSM
US$213.670.4%95.6%US$11.2bUS$285.4214.460.9%n/aPharmaceuticals & Biotech
SAUD3
R$13.77-3.0%7.6%R$40.3bR$17.6938.231.9%5.9%Healthcare
MOD
US$209.507.1%51.0%US$10.8bUS$310.2977.251.3%n/aCapital Goods
TGTX
US$48.74-2.0%73.6%US$6.8bUS$69.7115.721.3%n/aPharmaceuticals & Biotech
6990
HK$520.50-3.5%19.9%HK$124.4bHK$570.0551.945.1%n/aPharmaceuticals & Biotech
1729
HK$16.547.8%38.5%HK$36.9bHK$28.7547.137.1%0.3%Capital Goods
9218
JP¥749.00-0.4%-11.2%JP¥7.9bn/a33.128.9%1.3%Healthcare
002709
CN¥39.470.4%95.4%CN¥80.1bCN¥65.0827.928.3%0.6%Materials
601567
CN¥15.28-3.8%-36.9%CN¥21.4bCN¥35.7722.545.6%4.1%Capital Goods
002384
CN¥205.195.1%293.7%CN¥374.0bCN¥188.00183.373.1%0%Tech
688270
CN¥66.65-3.5%38.3%CN¥19.9bCN¥185.71132.885.5%0%Semiconductors
AV1
AU$0.07-2.8%-53.3%AU$64.9mAU$0.166.8107.8%n/aSoftware
2315
HK$69.0011.7%180.0%HK$65.7bHK$62.0391.241.0%n/aPharmaceuticals & Biotech
2368
NT$1,015.003.4%118.0%NT$513.0bNT$1,554.4445.244.0%1.0%Tech
300432
CN¥16.231.2%3.4%CN¥27.7bCN¥34.4054.860.7%0.6%Automobiles
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St